Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Why Sarepta Therapeutics Shares Shot Higher
Why Sarepta Therapeutics Shares Shot Higher
Why Sarepta Therapeutics Shares Shot Higher
Submitted by
admin
on February 27, 2013 - 5:25pm
Source:
Motley Fool
News Tags:
Sarepta
Duchenne Muscular Dystrophy
eteplirsen
Headline:
Why Sarepta Therapeutics Shares Shot Higher
Do Not Allow Advertisers to Use My Personal information